In the present year 2023, the net worth of total pharmaceutical plastic packaging products globally is likely to be around US$ 54,820.9 million. The global pharmaceutical plastic packaging market is projected to progress at a CAGR of 5.8% between the years 2023 and 2033. The pharmaceutical plastic packaging market analysis report predicts the net valuation to reach US$ 96,339.2 million by 2033.
The main reason for the positive growth rate in the adoption of pharmaceutical plastic packaging solutions is the development of various medications & drugs across countries. Moreover, the increasing prevalence of chronic diseases around the world has strengthened pharmaceutical companies to invest in custom pharmaceutical packaging solutions for export.
The pharmaceutical plastic packaging market is likely to have an upward trend from 2023 to 2033. Increasing consumption of food supplements and health consciousness are anticipated to keep the cash registers ringing in the pharmaceutical plastic packaging.
The global market is expected to expand 1.6 times its current market value in the next ten years. During this forecast period, it is projected to record a peak Y-o-Y of 6.5 % in the commercial year 2025 to 2026.
Despite these lucrative prospects, growth in the biologics market, and technological advancements are expected to further drive the drug delivery and drug packaging market ahead. Some recent market advancements include the use of innovative counterfeiting techniques and eco-friendly or biodegradable plastic packaging solutions.
| Attributes | Details |
|---|---|
| Pharmaceutical Plastic Packaging Market Size (2022) | US$ 51,926.7 million |
| Pharmaceutical Plastic Packaging Market Size (2023) | US$ 54,820.9 million |
| Pharmaceutical Plastic Packaging Projected Market Value (2033) | US$ 96,339.2 million |
| Global Pharmaceutical Plastic Packaging Market Growth Rate (2023 to 2033) | 5.8% CAGR |
| Collective Value Share: Top 3 Companies (2022E) | 33.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1 2021 | 4.0% |
| H1 2022 Projected | 4.9% |
| H1 2022 Expected | 5.1% |
| BPS Change - H1, 2022 (O) – H1, 2022 (P) | (+) 20 ↑ |
| BPS Change – H1, 2022 (O) – H1, 2021 | (+) 110 ↑ |
Future Market Insights predict a comparison and review analysis of the dynamics of the pharmaceutical plastic packaging market. It is principally subjected to an array of industry factors along with a few definite influences concerning strict government regulations & standards for drug packaging. Price volatility of raw materials can also restrain the growth of the custom pharmaceutical packaging market's key trends and opportunities.
The demand for pharmaceutical plastic packaging surged by 110 basis share points (BPS) in H1-2022 (O) against comparison with H1-2021, according to an FMI analysis. However, when comparing the H1-2022 projected and H1-2022 outlook period, a rise in BPS change by 20 BPS has been noticed.
Pharmaceutical Plastic Packaging Demand Analysis (2018 to 2022) Vs. Market Outlook (2023 to 2033)
The growing pharmaceutical industry and extensive research for developing new drugs are the fueling factors for the pharmaceutical packaging market. The introduction of plastic bottles and containers for pharmaceuticals is also creating exponential growth opportunities for pharmaceutical plastic packaging manufacturers across the globe.
Following the year 2020, the sales of child-resistant pharmaceutical plastic bottles for packaging solutions is growing steadily. As per FMI analysis, the child-resistant packaging market was worth around US$ 21 billion by the end of the year 2020.
Pharmaceutical plastic bottles used for packaging consist of child-resistant caps and closures. Child-safe packaging and contamination-free drug delivery are expected to amplify growth opportunities in sales of plastic bottles and containers for the pharmaceuticals market. This could be credited to the fact that it can be used for delivering cannabis-based medicine in a safe and commercially viable way.
Principal Consultant
Manufacturers of plastic packaging are developing pharmaceutical packaging solutions that are tamper-evident and possess anti-counterfeiting features, particularly for the exporting sector. Packaging with these two features can become an opportunity for biodegradable plastic packaging market players to make their products stand out amongst their competitors.
There has been a shift in demand for plastics-based medical packaging over glass packaging in the last few years. This could be reasoned by lower production costs and the wide availability of plastics worldwide. Furthermore, pharmaceutical plastic bottles are more convenient, durable, flexible, and sustainable as compared to glass. Also, sleeve labeling, the most preferred and widely used label is quite convenient in use on plastics as compared to glass.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
After the Covid-19 pandemic, the government’s prime focus is on devising new ways to reduce pressure on the healthcare system. From the year 2020, governments are exploring ways to move treatment out of hospitals into the home safely and efficiently.
Advanced tracking systems provided on the packaging are also increasing demand for pharmaceutical plastic packaging. Barcode-based and NFC chips on pharmaceutical plastic packaging solutions help to track the product easily and give real-time and predictive analysis to make up for the shortage of pharmaceutical products.
| Market Segments by Product Type | Ampules & Vials |
|---|---|
| Value in 2023 | US$ 8,372 million |
| CAGR (2023 to 2033) | 5.9% |
| Market Segments by Product Type | Bottles |
|---|---|
| Value in 2023 | US$ 20,033 million |
| CAGR (2023 to 2033) | 4.9% |
| Market Segments by Product Type | Blister Packs |
|---|---|
| Value in 2023 | US$ 10,116 million |
| CAGR (2023 to 2033) | 5% |
| Market Segments by Product Type | Trays |
|---|---|
| Value in 2023 | US$ 3,632 million |
| CAGR (2023 to 2033) | 7.9% |
| Market Segments by Product Type | Prefilled Syringes & Cartridges |
|---|---|
| Value in 2023 | US$ 6,073 million |
| CAGR (2023 to 2033) | 7.7% |
| Market Segments by Product Type | Bags & Pouches |
|---|---|
| Value in 2023 | US$ 4,341 million |
| CAGR (2023 to 2033) | 6.7% |
| Market Segments by Product Type | Other Products |
|---|---|
| Value in 2023 | US$ 2,255 million |
| CAGR (2023 to 2033) | 6.8% |
Further, as per FMI analysis, prefilled syringes and cartridges are expected to create an incremental opportunity of around US$ 6 billion in the subsequent 10 years. It can be attributed to the benefits of stress-free and safe subcutaneous drug delivery without the need for clinical monitoring.
| Market Segments by Material Type | Polythene (PE) |
|---|---|
| Value in 2023 | US$ 18,299.2 million |
| CAGR (2023 to 2033) | 5.1% |
| Market Segments by Material Type | Polypropylene (PP) |
|---|---|
| Value in 2023 | US$ 14,474.1 million |
| CAGR (2023 to 2033) | 6.4% |
| Market Segments by Material Type | Polyethylene Terephthalate (PET) |
|---|---|
| Value in 2023 | US$ 6,745.4 million |
| CAGR (2023 to 2033) | 6.3% |
| Market Segments by Material Type | Polyvinyl Chloride (PVC) |
|---|---|
| Value in 2023 | US$ 5,412.7 million |
| CAGR (2023 to 2033) | 4.8% |
| Market Segments by Material Type | Polyamide (PA) |
|---|---|
| Value in 2023 | US$ 3,631.4 million |
| CAGR (2023 to 2033) | 5% |
| Market Segments by Material Type | Cyclo-olefin Polymer (COP) |
|---|---|
| Value in 2023 | US$ 1,558.3 million |
| CAGR (2023 to 2033) | 9.4% |
| Market Segments by Material Type | Cyclo-olefin Copolymer (COC) |
|---|---|
| Value in 2023 | US$ 1,999.1 million |
| CAGR (2023 to 2033) | 7.1% |
| Market Segments by Material Type | Other Materials |
|---|---|
| Value in 2023 | US$ 2,700.7 million |
| CAGR (2023 to 2033) | 5.9% |
In the drug delivery category, oral drug delivery packaging leads the market share and the status quo is expected to remain unchanged even in the future. On-body delivery devices or wearable injectors are also widely being adopted by consumers, as these devices require minimum effort to inject the medicine. This in turn has provided sufficient impetus for pharmaceutical plastic bottle market players to increase their production capacity.
| Regional Market Attributes | Details |
|---|---|
| United States Market Size in 2023 | US$ 12,059 million |
| United States Market Size in 2033 | US$ 17,75.4 million |
| United States Market CAGR (2023 to 2033) | 3.6% |
In North America and Europe, the market growth is expected to decline slightly in the near future due to the restricted use of plastic material. However, a significant positive trend is anticipated in the coming days as manufacturers are emphasizing the guidelines for food and drug packaging. For instance, in April 2022, Amcor expanded its healthcare packaging capabilities in Europe following the guidelines circulated by the European Union.
| Regional Market Attributes | Details |
|---|---|
| Germany Market Size in 2023 | US$ 2,667.1 million |
| Germany Market Size in 2033 | US$ 3,690.2 million |
| Germany Market CAGR (2023 to 2033) | 3.3% |
The presence of several key players in these regions is key to an increased market share of pharmaceutical plastic packaging solutions. Tough rivalry among these players is anticipated as many regional players are entering the market.
| Regional Market Attributes | Details |
|---|---|
| China Market Size in 2023 | US$ 5,789.6 million |
| China Market Size in 2033 | US$ 13,211.3 million |
| China Market CAGR (2023 to 2033) | 8.6% |
South-East Asia is anticipated to generate a notable demand for flexible as well as rigid pharmaceutical plastic packaging, as entry restrictions are relatively less in the regions. Multiple growth opportunities for the key players are expected in the regions due to economic manufacturing facilities and other resources.
| Regional Market Attributes | Details |
|---|---|
| India Market Size in 2023 | US$ 2,845 million |
| India Market Size in 2033 | US$ 6,373.6 million |
| India Market CAGR (2023 to 2033) | 8.4% |
Less financial input required for the production of pharmaceutical plastic packaging is expected to attract manufacturers to reinforce their market position in India. Besides, pharmaceutical industries and research centers have led to an increasing demand for pharmaceutical plastic packaging in these regions.
| Regional Market Attributes | Details |
|---|---|
| Australia Market Size in 2023 | US$ 859.2 million |
| Australia Market Size in 2033 | US$ 1,399.4 million |
| Australia Market CAGR (2023 to 2033) | 5% |
Oceania and the Middle East & Africa are likely to create significant revenue-generating opportunities as regulatory complexity in these regions is less compared to other regions. Further, fewer key players in the regions are resulting in lenient market competition in the past three years. The expansion of the pharmaceutical industry in the region has resulted in the maximum production of pharmaceutical plastic packaging these days.
The overall market seems to be highly fragmented, as it is subject to many regional and organized players contributing to the market. Currently, the pharmaceutical plastic packaging market key players are focusing on providing tailored solutions as per the need of end-users. Packaging solution manufacturers are also emphasizing optimizing production capabilities and diversifying their product portfolio to fulfill the demand of the customers.
Leading manufacturers such as Gerresheimer AG, Amcor flexible SPS, and Oliver Tolas have increased the production of plastics-based sterile pharmaceutical packaging in the past few years. The manufacturers have emphasized the development of sustainable and biodegradable plastic packaging for pharmaceutical products.
For instance, in June 2020, Hoffman-Neopac AG introduced a recyclable high-performance Polyfoil® Mono-Material Barrier tube that provides excellent product protection via certified food- and pharma-grade materials. This tube is entirely made from polyethylene (PE) material and the tube weight is reduced by almost 40% as compared to standard tubes.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million or billion for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Italy, Spain, Benelux, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Singapore, China, Japan, South Korea, Australia, New Zealand, Türkiye, Egypt, North Africa, South Africa, and GCC Countries |
| Key Market Segments Covered | By Product Type, By Packaging Type, By Material Type, By Drug Delivery Mode, and By Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The market is anticipated to reach US$ 96,339.2 million by 2033.
In 2023, the market size is estimated to be US$ 54,820.9 million.
Gerresheimer AG, SCHOTT AG, and Alpha Packaging Holdings Inc are the key players.
The growth potential of the market is 5.8% through 2033.
The United States, Japan, and China dominate the global market.
1. Executive Summary | Pharmaceutical Plastic Packaging Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Tonnes) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Tonnes) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Raw Material 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Tonnes) Analysis By Raw Material, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Tonnes) Analysis and Forecast By Raw Material, 2023 to 2033 5.3.1. Polypropylene 5.3.2. Polyethylene Terephthalate 5.3.3. Low Density Polyethylene 5.3.4. High Density Polyethylene 5.4. Y-o-Y Growth Trend Analysis By Raw Material, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Raw Material, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Tonnes) Analysis By Product Type, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Tonnes) Analysis and Forecast By Product Type, 2023 to 2033 6.3.1. Solid Containers 6.3.2. Dropper Bottles 6.3.3. Nasal Spray Bottles 6.3.4. Liquid Bottles 6.3.5. Oral Care 6.3.6. Pouches 6.3.7. Vials & Ampoules 6.3.8. Cartridges 6.3.9. Syringes 6.3.10. Caps & Closures 6.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Packaging Type 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Tonnes) Analysis By Packaging Type, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Tonnes) Analysis and Forecast By Packaging Type, 2023 to 2033 7.3.1. Primary 7.3.2. Secondary 7.3.3. Tertiary 7.4. Y-o-Y Growth Trend Analysis By Packaging Type, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Packaging Type, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Delivery Mode 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) & Volume (Tonnes) Analysis By Drug Delivery Mode, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) & Volume (Tonnes) Analysis and Forecast By Drug Delivery Mode, 2023 to 2033 8.3.1. Oral Drug Delivery Packaging 8.3.2. Injectable Packaging 8.3.3. Topical Drug Delivery Packaging 8.3.4. Pulmonary Drug Delivery Packaging 8.3.5. Transdermal Drug Delivery Packaging 8.3.6. Ocular Drug Delivery Packaging 8.3.7. Nasal Drug Delivery Packaging 8.3.8. Other Drug Delivery Packaging 8.4. Y-o-Y Growth Trend Analysis By Drug Delivery Mode, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By Drug Delivery Mode, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) & Volume (Tonnes) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) & Volume (Tonnes) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. Asia Pacific 9.3.5. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Tonnes) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Tonnes) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. USA 10.2.1.2. Canada 10.2.2. By Raw Material 10.2.3. By Product Type 10.2.4. By Packaging Type 10.2.5. By Drug Delivery Mode 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Raw Material 10.3.3. By Product Type 10.3.4. By Packaging Type 10.3.5. By Drug Delivery Mode 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Tonnes) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Tonnes) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Raw Material 11.2.3. By Product Type 11.2.4. By Packaging Type 11.2.5. By Drug Delivery Mode 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Raw Material 11.3.3. By Product Type 11.3.4. By Packaging Type 11.3.5. By Drug Delivery Mode 11.4. Key Takeaways 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Tonnes) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Tonnes) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. United Kingdom 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Raw Material 12.2.3. By Product Type 12.2.4. By Packaging Type 12.2.5. By Drug Delivery Mode 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Raw Material 12.3.3. By Product Type 12.3.4. By Packaging Type 12.3.5. By Drug Delivery Mode 12.4. Key Takeaways 13. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Tonnes) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Tonnes) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.1.4. Singapore 13.2.1.5. Thailand 13.2.1.6. Indonesia 13.2.1.7. Australia 13.2.1.8. New Zealand 13.2.1.9. Rest of Asia Pacific 13.2.2. By Raw Material 13.2.3. By Product Type 13.2.4. By Packaging Type 13.2.5. By Drug Delivery Mode 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Raw Material 13.3.3. By Product Type 13.3.4. By Packaging Type 13.3.5. By Drug Delivery Mode 13.4. Key Takeaways 14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Tonnes) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Tonnes) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Raw Material 14.2.3. By Product Type 14.2.4. By Packaging Type 14.2.5. By Drug Delivery Mode 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Raw Material 14.3.3. By Product Type 14.3.4. By Packaging Type 14.3.5. By Drug Delivery Mode 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Raw Material 15.1.2.2. By Product Type 15.1.2.3. By Packaging Type 15.1.2.4. By Drug Delivery Mode 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Raw Material 15.2.2.2. By Product Type 15.2.2.3. By Packaging Type 15.2.2.4. By Drug Delivery Mode 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Raw Material 15.3.2.2. By Product Type 15.3.2.3. By Packaging Type 15.3.2.4. By Drug Delivery Mode 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Raw Material 15.4.2.2. By Product Type 15.4.2.3. By Packaging Type 15.4.2.4. By Drug Delivery Mode 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Raw Material 15.5.2.2. By Product Type 15.5.2.3. By Packaging Type 15.5.2.4. By Drug Delivery Mode 15.6. United Kingdom 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Raw Material 15.6.2.2. By Product Type 15.6.2.3. By Packaging Type 15.6.2.4. By Drug Delivery Mode 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Raw Material 15.7.2.2. By Product Type 15.7.2.3. By Packaging Type 15.7.2.4. By Drug Delivery Mode 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Raw Material 15.8.2.2. By Product Type 15.8.2.3. By Packaging Type 15.8.2.4. By Drug Delivery Mode 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Raw Material 15.9.2.2. By Product Type 15.9.2.3. By Packaging Type 15.9.2.4. By Drug Delivery Mode 15.10. China 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Raw Material 15.10.2.2. By Product Type 15.10.2.3. By Packaging Type 15.10.2.4. By Drug Delivery Mode 15.11. Japan 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Raw Material 15.11.2.2. By Product Type 15.11.2.3. By Packaging Type 15.11.2.4. By Drug Delivery Mode 15.12. South Korea 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Raw Material 15.12.2.2. By Product Type 15.12.2.3. By Packaging Type 15.12.2.4. By Drug Delivery Mode 15.13. Singapore 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Raw Material 15.13.2.2. By Product Type 15.13.2.3. By Packaging Type 15.13.2.4. By Drug Delivery Mode 15.14. Thailand 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Raw Material 15.14.2.2. By Product Type 15.14.2.3. By Packaging Type 15.14.2.4. By Drug Delivery Mode 15.15. Indonesia 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Raw Material 15.15.2.2. By Product Type 15.15.2.3. By Packaging Type 15.15.2.4. By Drug Delivery Mode 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Raw Material 15.16.2.2. By Product Type 15.16.2.3. By Packaging Type 15.16.2.4. By Drug Delivery Mode 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Raw Material 15.17.2.2. By Product Type 15.17.2.3. By Packaging Type 15.17.2.4. By Drug Delivery Mode 15.18. GCC Countries 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Raw Material 15.18.2.2. By Product Type 15.18.2.3. By Packaging Type 15.18.2.4. By Drug Delivery Mode 15.19. South Africa 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Raw Material 15.19.2.2. By Product Type 15.19.2.3. By Packaging Type 15.19.2.4. By Drug Delivery Mode 15.20. Israel 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Raw Material 15.20.2.2. By Product Type 15.20.2.3. By Packaging Type 15.20.2.4. By Drug Delivery Mode 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Raw Material 16.3.3. By Product Type 16.3.4. By Packaging Type 16.3.5. By Drug Delivery Mode 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Gerresheimer AG 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. SCHOTT AG 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Alpha Packaging Holdings Inc. 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Klöckner Pentaplast Group 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Amcor Plc 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Berry Global, Inc. 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Becton, Dickinson and Company 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. Parekhplast India Ltd 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. West Pharmaceutical Services, Inc. 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Wipak Group 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 17.1.11. Mondi Plc 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.11.5.2. Product Strategy 17.1.11.5.3. Channel Strategy 17.1.12. Sealed Air Corporation 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.12.5.2. Product Strategy 17.1.12.5.3. Channel Strategy 17.1.13. Constantia Flexibles Group GmbH 17.1.13.1. Overview 17.1.13.2. Product Portfolio 17.1.13.3. Profitability by Market Segments 17.1.13.4. Sales Footprint 17.1.13.5. Strategy Overview 17.1.13.5.1. Marketing Strategy 17.1.13.5.2. Product Strategy 17.1.13.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Packaging Insights
View Reports
Pharmaceutical Plastic Packaging Market
